Carregant...
Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
Direct-acting antivirals (DAA) have revolutionized the treatment of patients with chronic hepatitis C virus (HCV) infection, possibly leading to HCV elimination by 2030 as endorsed by the World Health Organization (WHO). However, some patients belonging to the so-called unique or special populations...
Guardat en:
| Publicat a: | Viruses |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8228389/ https://ncbi.nlm.nih.gov/pubmed/34205966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13061048 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|